Weekly Roundup: Experts Challenge Vaccine Claims, Cannabis Addiction, and Energy Drink Marketing

In this week's compilation of notable remarks, experts questioned the reliability of vaccine information from political leaders, highlighted rising cannabis use disorder rates, and urged the NCAA to drop energy drink sponsorships. Other comments addressed the limitations of BMI in older adults, potential benefits of creatine, and challenges patients face understanding online test results.

This week's commentary spans several public health concerns. Vaccine experts questioned the reliability of immunization guidance from political figures, while allergists noted the end of the only FDA-approved oral treatment for pediatric peanut allergies. Addiction researchers reported that cannabis use disorder appears more prevalent among users than previously understood, and cardiologists challenged the NCAA's sponsorship agreements with energy drink manufacturers, citing a lack of health benefits.

Additional remarks addressed clinical measurement and patient communication. Researchers cautioned that BMI alone fails to capture mortality risk in older adults, though they stopped short of endorsing weight gain. Physical therapists pointed to creatine's potential for enhancing strength, while nutrition scientists criticized the process behind updated federal dietary guidelines. Finally, public health scholars emphasized that patients frequently access online test results but often cannot interpret them without clearer presentation.